192 related articles for article (PubMed ID: 31121581)
1. Two-Year Follow-Up after Treatment with the Cognitive Behavioral Analysis System of Psychotherapy versus Supportive Psychotherapy for Early-Onset Chronic Depression.
Schramm E; Kriston L; Elsaesser M; Fangmeier T; Meister R; Bausch P; Zobel I; Bailer J; Wambach K; Backenstrass M; Klein JP; Schoepf D; Schnell K; Gumz A; Löwe B; Walter H; Wolf M; Domschke K; Berger M; Hautzinger M; Härter M
Psychother Psychosom; 2019; 88(3):154-164. PubMed ID: 31121581
[TBL] [Abstract][Full Text] [Related]
2. Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial.
Schramm E; Kriston L; Zobel I; Bailer J; Wambach K; Backenstrass M; Klein JP; Schoepf D; Schnell K; Gumz A; Bausch P; Fangmeier T; Meister R; Berger M; Hautzinger M; Härter M
JAMA Psychiatry; 2017 Mar; 74(3):233-242. PubMed ID: 28146251
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Childhood Maltreatment on Long-Term Outcomes in Disorder-Specific vs. Nonspecific Psychotherapy for Chronic Depression.
Bausch P; Fangmeier T; Meister R; Elsaeßer M; Kriston L; Klein JP; Zobel I; Hautzinger M; Härter M; Schramm E
J Affect Disord; 2020 Jul; 272():152-157. PubMed ID: 32379608
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Chronic Major Depression.
Schramm E; Zobel I; Schoepf D; Fangmeier T; Schnell K; Walter H; Drost S; Schmidt P; Brakemeier EL; Berger M; Normann C
Psychother Psychosom; 2015; 84(4):227-40. PubMed ID: 26022410
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of the Cognitive Behavioral Analysis System of Psychotherapy versus supportive psychotherapy for early onset chronic depression: design and rationale of a multisite randomized controlled trial.
Schramm E; Hautzinger M; Zobel I; Kriston L; Berger M; Härter M
BMC Psychiatry; 2011 Aug; 11():134. PubMed ID: 21849054
[TBL] [Abstract][Full Text] [Related]
6. Group Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for persistently depressed outpatients: a retrospective chart review.
Potijk MR; Aan Het Rot M; Parlevliet FM; Schoevers RA; Eldering MJ
Br J Clin Psychol; 2020 Nov; 59(4):552-564. PubMed ID: 32920864
[TBL] [Abstract][Full Text] [Related]
7. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Schatzberg AF; Rush AJ; Arnow BA; Banks PL; Blalock JA; Borian FE; Howland R; Klein DN; Kocsis JH; Kornstein SG; Manber R; Markowitz JC; Miller I; Ninan PT; Rothbaum BO; Thase ME; Trivedi MH; Keller MB
Arch Gen Psychiatry; 2005 May; 62(5):513-20. PubMed ID: 15867104
[TBL] [Abstract][Full Text] [Related]
8. REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.
Trivedi MH; Kocsis JH; Thase ME; Morris DW; Wisniewski SR; Leon AC; Gelenberg AJ; Klein DN; Niederehe G; Schatzberg AF; Ninan PT; Keller MB
Psychopharmacol Bull; 2008; 41(4):5-33. PubMed ID: 19015627
[TBL] [Abstract][Full Text] [Related]
9. Cognitive Behavioral Analysis System of Psychotherapy as group psychotherapy for chronically depressed inpatients: a naturalistic multicenter feasibility trial.
Sabaß L; Padberg F; Normann C; Engel V; Konrad C; Helmle K; Jobst A; Worlitz A; Brakemeier EL
Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):783-796. PubMed ID: 28956140
[TBL] [Abstract][Full Text] [Related]
10. Impact of Baseline Characteristics on the Effectiveness of Disorder-Specific Cognitive Behavioral Analysis System of Psychotherapy (CBASP) and Supportive Psychotherapy in Outpatient Treatment for Persistent Depressive Disorder.
Serbanescu I; Backenstrass M; Drost S; Weber B; Walter H; Klein JP; Zobel I; Hautzinger M; Meister R; Härter M; Schramm E; Schoepf D
Front Psychiatry; 2020; 11():607300. PubMed ID: 33408656
[No Abstract] [Full Text] [Related]
11. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
Kocsis JH; Gelenberg AJ; Rothbaum BO; Klein DN; Trivedi MH; Manber R; Keller MB; Leon AC; Wisniewski SR; Arnow BA; Markowitz JC; Thase ME;
Arch Gen Psychiatry; 2009 Nov; 66(11):1178-88. PubMed ID: 19884606
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronically depressed patients: a multisite randomized controlled trial testing the effectiveness of 'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) for chronic depressions versus usual secondary care.
Wiersma JE; van Schaik DJ; van Oppen P; McCullough JP; Schoevers RA; Dekker JJ; Blom MB; Maas K; Smit JH; Penninx BW; Beekman AT
BMC Psychiatry; 2008 Mar; 8():18. PubMed ID: 18366729
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial on the efficacy of mindfulness-based cognitive therapy and a group version of cognitive behavioral analysis system of psychotherapy for chronically depressed patients.
Michalak J; Schultze M; Heidenreich T; Schramm E
J Consult Clin Psychol; 2015 Oct; 83(5):951-63. PubMed ID: 26371617
[TBL] [Abstract][Full Text] [Related]
14. Comparing the Efficacy of CBASP with Two Versions of CBT for Depression in a Routine Care Center: A Randomized Clinical Trial.
Rief W; Bleichhardt G; Dannehl K; Euteneuer F; Wambach K
Psychother Psychosom; 2018; 87(3):164-178. PubMed ID: 29649805
[TBL] [Abstract][Full Text] [Related]
15. The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: A secondary analysis.
Bausch P; Fangmeier T; Zobel I; Schoepf D; Drost S; Schnell K; Walter H; Berger M; Normann C; Schramm E
Clin Psychol Psychother; 2017 Sep; 24(5):1155-1162. PubMed ID: 28326653
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Clusters of Long-Term Trajectories in Patients with Early-Onset Chronic Depression: 2 Years of Naturalistic Follow-Up after Extensive Psychological Treatment.
Elsaesser M; Feige B; Kriston L; Schumacher L; Peifer J; Hautzinger M; Härter M; Schramm E
Psychother Psychosom; 2024; 93(1):65-74. PubMed ID: 38154457
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
Thase ME; Rush AJ; Manber R; Kornstein SG; Klein DN; Markowitz JC; Ninan PT; Friedman ES; Dunner DL; Schatzberg AF; Borian FE; Trivedi MH; Keller MB
J Clin Psychiatry; 2002 Jun; 63(6):493-500. PubMed ID: 12088160
[TBL] [Abstract][Full Text] [Related]
18. Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients.
Assmann N; Schramm E; Kriston L; Hautzinger M; Härter M; Schweiger U; Klein JP
Depress Anxiety; 2018 Oct; 35(10):1001-1008. PubMed ID: 30199128
[TBL] [Abstract][Full Text] [Related]
19. Adverse events during a disorder-specific psychotherapy compared to a nonspecific psychotherapy in patients with chronic depression.
Meister R; Lanio J; Fangmeier T; Härter M; Schramm E; Zobel I; Hautzinger M; Nestoriuc Y; Kriston L
J Clin Psychol; 2020 Jan; 76(1):7-19. PubMed ID: 31576565
[TBL] [Abstract][Full Text] [Related]
20. Oxytocin plasma levels predict the outcome of psychotherapy: A pilot study in chronic depression.
Jobst A; Sabaß L; Hall D; Brücklmeier B; Buchheim A; Hall J; Sarubin N; Zill P; Falkai P; Brakemeier EL; Padberg F
J Affect Disord; 2018 Feb; 227():206-213. PubMed ID: 29100154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
